Pivotal trial of the efficacy and safety of oxymetazoline cream 1.0% for the treatment of persistent facial erythema associated with rosacea: Findings from the Second Reveal trial

Leslie Baumann, David J. Goldberg, Linda Stein Gold, Emil A. Tanghetti, Edward Lain, Joely Kaufman, Emily Weng, David R. Berk, Gurpreet Ahluwalia

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Pivotal trial of the efficacy and safety of oxymetazoline cream 1.0% for the treatment of persistent facial erythema associated with rosacea: Findings from the Second Reveal trial'. Together they form a unique fingerprint.

Medicine & Life Sciences